Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.

Corti D, Bianchi S, Vanzetta F, Minola A, Perez L, Agatic G, Guarino B, Silacci C, Marcandalli J, Marsland BJ, Piralla A, Percivalle E, Sallusto F, Baldanti F, Lanzavecchia A.

Nature. 2013 Sep 19;501(7467):439-43. doi: 10.1038/nature12442. Epub 2013 Aug 18.

PMID:
23955151
2.

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z, Burton DR, Williamson RA, Williams JV.

J Infect Dis. 2015 Jan 15;211(2):216-25. doi: 10.1093/infdis/jiu307. Epub 2014 May 26.

3.

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.

Magro M, Mas V, Chappell K, Vázquez M, Cano O, Luque D, Terrón MC, Melero JA, Palomo C.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3089-94. doi: 10.1073/pnas.1115941109. Epub 2012 Feb 8.

4.

Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site.

Wen X, Krause JC, Leser GP, Cox RG, Lamb RA, Williams JV, Crowe JE Jr, Jardetzky TS.

Nat Struct Mol Biol. 2012 Mar 4;19(4):461-3. doi: 10.1038/nsmb.2250.

5.

Bovine model of respiratory syncytial virus infection.

Taylor G.

Curr Top Microbiol Immunol. 2013;372:327-45. doi: 10.1007/978-3-642-38919-1_16.

PMID:
24362697
6.

Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.

Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J.

J Virol. 2014 Oct;88(19):11411-29. doi: 10.1128/JVI.00876-14. Epub 2014 Jul 23.

7.

Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.

Ulbrandt ND, Ji H, Patel NK, Riggs JM, Brewah YA, Ready S, Donacki NE, Folliot K, Barnes AS, Senthil K, Wilson S, Chen M, Clarke L, MacPhail M, Li J, Woods RM, Coelingh K, Reed JL, McCarthy MP, Pfarr DS, Osterhaus AD, Fouchier RA, Kiener PA, Suzich JA.

J Virol. 2006 Aug;80(16):7799-806.

8.

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Blodörn K, Hägglund S, Fix J, Dubuquoy C, Makabi-Panzu B, Thom M, Karlsson P, Roque JL, Karlstam E, Pringle J, Eléouët JF, Riffault S, Taylor G, Valarcher JF.

PLoS One. 2014 Jun 19;9(6):e100392. doi: 10.1371/journal.pone.0100392. eCollection 2014.

9.

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.

Ulbrandt ND, Ji H, Patel NK, Barnes AS, Wilson S, Kiener PA, Suzich J, McCarthy MP.

J Gen Virol. 2008 Dec;89(Pt 12):3113-8. doi: 10.1099/vir.0.2008/005199-0.

10.

Immunization strategies for the prevention of pneumovirus infections.

Bennett N, Ellis J, Bonville C, Rosenberg H, Domachowske J.

Expert Rev Vaccines. 2007 Apr;6(2):169-82. Review.

PMID:
17408367
11.

Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.

Ebihara T, Endo R, Kikuta H, Ishiguro N, Ishiko H, Kobayashi K.

J Med Virol. 2004 Feb;72(2):304-6.

PMID:
14695674
12.

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.

Tang RS, Mahmood K, Macphail M, Guzzetta JM, Haller AA, Liu H, Kaur J, Lawlor HA, Stillman EA, Schickli JH, Fouchier RA, Osterhaus AD, Spaete RR.

Vaccine. 2005 Feb 25;23(14):1657-67.

PMID:
15705469
13.

Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China.

Lu G, Gonzalez R, Guo L, Wu C, Wu J, Vernet G, Paranhos-Baccalà G, Wang J, Hung T.

Virol J. 2011 Feb 10;8:62. doi: 10.1186/1743-422X-8-62.

14.

Dendritic cells in human Pneumovirus and Metapneumovirus infections.

Guerrero-Plata A.

Viruses. 2013 Jun 20;5(6):1553-70. doi: 10.3390/v5061553. Review.

15.

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR.

J Virol. 2004 Jul;78(13):6927-37.

17.
18.

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE Jr, Williamson RA.

J Virol. 2007 Aug;81(15):8315-24. Epub 2007 May 23.

19.

A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Zhang Y, Brooks WA, Goswami D, Rahman M, Luby SP, Erdman DD.

J Virol Methods. 2014 Sep;206:55-62. doi: 10.1016/j.jviromet.2014.05.008. Epub 2014 May 23.

PMID:
24859050
20.

Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE Jr.

J Immunol. 2013 Apr 1;190(7):3732-9. doi: 10.4049/jimmunol.1202964. Epub 2013 Mar 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk